TEVA PHARMACEUTICAL-SP ADR (TEVA)
US8816242098 - ADR
June 7th Options Now Available For Teva Pharmaceutical Industries
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead
Three highly successful billionaire money managers are paring down their respective stakes in artificial intelligence (AI) titan Nvidia and purchasing shares of six beaten-down value stocks.
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
3 No-Brainer Stocks to Buy With $600 Right Now
A relatively modest amount of money can go a long way when it's put to work in top-tier businesses with abundant catalysts.
UroGen stock falls as Teva seeks Jelmyto generic (NASDAQ:URGN)
Shares of UroGen Pharma (URGN) fell after Teva Pharma (TEVA) filed for FDA approval of a generic version of URGN's bladder cancer therapy, Jelmyto. Read more here.
April 12th Options Now Available For Teva Pharmaceutical Industries
Drug Maker Organon Stock Scores Relative Strength Upgrade
In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday.
Ethereum Price Predictions: Where Will the ETH Crypto Go After Retaking $3,000?
Ethereum price predictions are a hot topic on Monday as crypto traders wonder where the token will go after surpassing $3,000.
Jefferies Just Raised Its Price Target on Salesforce (CRM) Stock
Salesforce stock is rising higher on Monday after CRM shares got an increased price target from Jefferies analysts this morning.
TEVA Stock Pops 4% as Teva Receives FDA Approval
Teva Pharmaceutical stock is rising higher on Monday after partner company Alvotech got approval from the FDA for a Humira biosimilar.
Teva and Jiangsu announce partnership for distribution of AUSTEDO in China (NYSE:TEVA)
Teva Pharmaceutical and Jiangsu Nhwa forge a strategic partnership to enhance patient access to AUSTEDO, a drug for neurodegenerative and movement...
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China
Alvotech/Teva win FDA approval for Humira biosimilar (NASDAQ:ALVO)
Alvotech and Teva Pharmaceuticals receive FDA approval for arthritis injection, Simlandi. It is the first biosimilar to AbbVie's Humira in the US.
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Interesting TEVA Put And Call Options For April 19th
Glenview Capital takes in Marvell, cuts stake in Intel and exits Microsoft (NASDAQ:MRVL)
Glenview Capital Management took new positions in Marvell Technology (MRVL) and CVS Health (CVS) in Q4 2023. Read more here.